In a letter addressed to Congress, and organized by Competitive Enterprise Institute, the undersigned organizations express their strong concerns regarding the Inflation Reduction Act (IRA), particularly its provisions related to prescription drug price controls. The coalition argues that the IRA’s prescription drug price control regime is unnecessary, as it focuses Read more…
In the world of intellectual property, inventors and innovators have long relied on the protection of patents to safeguard their creations. However, in recent years, the Patent Trial and Appeal Board (PTAB) has become a contentious battleground where patents are challenged and, in some cases, invalidated. Market Institute President Charles Read more…
Just over a year ago, President Biden aimed to lead the nation towards innovation and collaboration, promoting research and unity to solve one of modern life’s biggest challenges—cancer. The United States has a long history of innovation, driven by a patent system that protects inventors and encourages investment in research Read more…
The National Institutes of Health has asked the public to submit written comments responding to a Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer. See comment below: More innovation is fairly easy – create the right incentives For good or bad – people, businesses, investors, Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Policy looking at the problems with price setting drug prices. There are attempts by the Biden Administration to use “March In” rights to implement price controls – even at the expense of future innovation. He writes: “In Read more…
The Market Institute President Charles Sauer has a new article in The Washington Examiner’s Restoring America series on whether Congress is ready to finally pull the plug on the patent killing Patent Trial and Appeal Board. He writes: “We all know the basic plot of gladiator-style movies : The underdog battles in Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Markets arguing the important of patents to the American economy. Innovation will undoubtedly suffer in this country if patents are weakened. He writes: “While many rights in the Constitution are defined vaguely, the Founders laid out one Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Markets on a patent bill in Congress that would harm small inventors. He writes: “Republicans have opposed registering guns, they have opposed naming donors to non-profits, they have supported limited government – all ideologically sound, good libertarian Read more…
The Market Institute President Charles Sauer has a new piece in Real Clear Markets looking at Senator Patrick Leahy’s ill-advised group of patent bills. He writes: “I sometimes find myself humming or listening tunes from the 90s while doing things around the house or bopping down the road, reminding myself Read more…
The Market Institute President Charles Sauer has a new article in the Washington Examiner’s Restoring America series looking at why Senator Patrick Leahy (D-VT) is ending his tenure in the Senate with a patent bill that will harm inventors. “The 47-year-serving Democratic senator from Vermont, Patrick Leahy, is finishing his Read more…